CD14 and atherosclerosis: Intermediate monocytes (CD14++/CD16+) and non-classical monocytes (CD14+/CD16+) have been shown to have the characteristics of activated cells, exhibit a pro-inflammatory nature and may contribute to atherosclerosis [24,59].